Upgrade to SI Premium - Free Trial

Globus Medical (GMED) PT Lowered to $70 at Stifel

May 9, 2025 5:40 AM
Stifel analyst Mathew Blackman lowered the price target on Globus Medical (NYSE: GMED) to $70.00 (from $94.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles